Indeed, the dichotomous effect of TRAIL on malignant cells (early induction of apoptosis and monocytic maturation of the surviving cells) might have important therapeutic implications for the treatment of AML [11]. This evidence concerns the gene TNFSF10 and acute myeloid leukemia.